<DOC>
	<DOCNO>NCT01107145</DOCNO>
	<brief_summary>The current treatment recommendation P. vivax pregnant non-pregnant individual use chloroquine ; non-pregnant patient follow primaquine prevent relapse . As primaquine use pregnant woman , woman remain risk relapse . As increase concern chloroquine resistant P. vivax region , need identify alternative treatment option . The artemisinin combination therapy recommend use P. falciparum infection pregnant woman 1st trimester ; additional data need support use drug P. vivax .</brief_summary>
	<brief_title>Efficacy Artemisinin Combination Therapies Treatment Uncomplicated P. Vivax Pregnancy Brazil ( PAACT-PV )</brief_title>
	<detailed_description />
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Malaria , Vivax</mesh_term>
	<mesh_term>Lumefantrine</mesh_term>
	<mesh_term>Artemether</mesh_term>
	<mesh_term>Artemisinins</mesh_term>
	<mesh_term>Artemether-lumefantrine combination</mesh_term>
	<mesh_term>Artesunate</mesh_term>
	<mesh_term>Chloroquine</mesh_term>
	<mesh_term>Chloroquine diphosphate</mesh_term>
	<mesh_term>Mefloquine</mesh_term>
	<criteria>Gestational age &gt; 16 week ( determine LMP fundal height ) discordance two , conservative estimate ( i.e . low ) use , prevent accidental exposure 1st trimester fetus Normal fetal heart beat detect Doppler Presence asexual P. vivax parasitemia â‰¤ 50,000 parasites/microliter ( thick smear ) Willing sign thumb print inform consent Willing return schedule follow visit treatment observation delivery Willing deliver health facility Pregnancy &lt; 16 week Microscopically confirm P. falciparum mixed infection/ parasitemia ( P. vivax another specie Plasmodium , i.e . P. vivax , P. ovale , P. malariae ) History allergy hypersensitivity interventional drug Exposure antimalarial drug drug antimalarial activity within past 2 month , determine history woman ( quinine , mefloquine , artemisinin derivative , include AL MA ) Patients take drug possible interaction study drug ( ie . warfarin , digoxin ) History family history epilepsy psychiatric disorder Presence sign symptom severe malaria , severe illness , danger sign Hemoglobin &lt; 7 g/dl Inability tolerate oral medication ( repeat vomiting , impairment consciousness ) . History chronic disease include diabetes , renal failure , hepatic failure , heart disease require antiarrhythmic drug warfarin , HIV/ AIDS , know hemoglobinopathy Participant 's inability return follow visit Age &lt; 15 year</criteria>
	<gender>Female</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Plasmodium</keyword>
	<keyword>Vivax</keyword>
	<keyword>Malaria</keyword>
	<keyword>Pregnancy</keyword>
	<keyword>Brazil</keyword>
	<keyword>Treatment</keyword>
</DOC>